Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Stock Position Reduced by New Age Alpha Advisors LLC

Key Points

• New Age Alpha Advisors LLC reduced its position in Walgreens Boots Alliance by 90.4%, selling 382,839 shares and holding 40,435 shares worth $452,000 as of its latest SEC filing.
• Walgreens Boots Alliance reported quarterly earnings of $0.38 EPS, beating expectations of $0.34, with revenues of $38.99 billion, up 7.2% year-over-year.
• Analyst ratings for Walgreens Boots Alliance include four sell ratings, seven hold ratings, and two buy ratings, resulting in a consensus rating of "Hold" and a target price of $10.59.

New Age Alpha Advisors LLC trimmed its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 90.4% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,435 shares of the pharmacy operator's stock after selling 382,839 shares during the period. New Age Alpha Advisors LLC's holdings in Walgreens Boots Alliance were worth $452,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in WBA. Colonial Trust Co SC boosted its holdings in Walgreens Boots Alliance by 79.5% during the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock valued at $27,000 after acquiring an additional 1,297 shares during the period. Sentry Investment Management LLC acquired a new stake in Walgreens Boots Alliance in the first quarter valued at approximately $27,000. Curat Global LLC purchased a new position in Walgreens Boots Alliance during the 1st quarter worth $27,000. Federated Hermes Inc. raised its position in shares of Walgreens Boots Alliance by 135.8% in the 1st quarter. Federated Hermes Inc. now owns 3,152 shares of the pharmacy operator's stock valued at $35,000 after purchasing an additional 1,815 shares during the last quarter. Finally, N.E.W. Advisory Services LLC acquired a new stake in shares of Walgreens Boots Alliance during the first quarter worth $43,000. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Stock Up 0.3%

NASDAQ:WBA traded up $0.04 during mid-day trading on Friday, hitting $11.94. The company had a trading volume of 7,572,244 shares, compared to its average volume of 5,993,019. The company has a current ratio of 0.60, a quick ratio of 0.32 and a debt-to-equity ratio of 0.96. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $13.25. The business has a fifty day simple moving average of $11.49 and a 200-day simple moving average of $11.10. The firm has a market capitalization of $10.33 billion, a price-to-earnings ratio of -1.64, a PEG ratio of 1.40 and a beta of 0.80.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 EPS for the quarter, topping the consensus estimate of $0.34 by $0.04. The business had revenue of $38.99 billion for the quarter, compared to analysts' expectations of $36.72 billion. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The company's quarterly revenue was up 7.2% compared to the same quarter last year. During the same quarter last year, the company posted $0.63 earnings per share. Equities analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts recently issued reports on WBA shares. Morgan Stanley reissued an "underweight" rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. UBS Group reaffirmed a "neutral" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Finally, Wall Street Zen started coverage on shares of Walgreens Boots Alliance in a research report on Wednesday, May 21st. They issued a "hold" rating for the company. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.